Publikationsliste

Hier sehen Sie unsere aktuellen Publikationen gegliedert nach Indikationsgebieten.

Weitere Informationen zu unseren aktuellen Forschungsarbeiten erhalten Sie von Frau Claudia Kohlbrenner: claudia.kohlbrenner@thermofisher.com

Über eine Auswahl einer Unterkategorie können Sie die Suche starten:

 

Infektion
 
 
 
 Schulte J, Struck J, Köhrle J, Müller B.
Circulating levels of Peroxiredoxin 4 as a Novel Biomarker of Oxidative Stress in Patients with Sepsis.
Shock. 2011 May;35(5):460-5


Krüger S, Ewig S, Kunde J, Hartmann O, Marre R, Suttorp N, Welte T; on behalf of the CAPNETZ study group.
Assessment of inflammatory markers in patients with community-acquired pneumonia - Influence of antimicrobial pre-treatment Results from the German competence network CAPNETZ.
Clin Chim Acta. 2010 Dec 14;411(23-24):1929-34.


Burkhardt O, Ewig S, Haagen U, Giersdorf S, Hartmann O, Wegscheider K, Hummers-Pradier E, Welte T.
Procalcitonin guidance and reduction of antibiotic use in acute respiratory tract infection.
Eur Respir J. 2010 Sep;36(3):601-7.




Limper M, Goeijenbier M, Wagenaar JF, Gasem MH, Isbandrio B, Kunde J, Hartmann O, Duits AJ, Van Gorp EC.
Copeptin as a predictor of disease severity and survival in leptospirosis.
J Infect. 2010 Jul;61(1):92-4.




Struck J, Strebelow M, Tietz S, Alonso C, Morgenthaler NG, van der Hoeven JG, Pickkers P, Bergmann A.
Method for the Selective Measurement of Amino-Terminal Variants of Procalcitonin.
Clin Chem. 2009 Sep;55(9):1672-9.


Krüger S, Ewig S, Kunde J, Hanschmann A, Marre R, Suttorp N, Welte T; on behalf of the CAPNETZ study group.
C-terminal provasopressin (copeptin) in patients with community-acquired pneumonia--influence of antibiotic pre-treatment: results from the German competence network CAPNETZ.
J Antimicrob Chemother. 2009 Jul;64(1):159-62


Hollenbach B, Morgenthaler NG, Struck J, Alonso C, Bergmann A, Köhrle J, Schomburg L.
New assay for the measurement of selenoprotein P as a sepsis biomarker from serum.
J Trace Elem Med Biol. 2008;22(1):24-32



Immunoluminometric assay for measurement of the C-terminal endothelin-1 precursor fragment in human plasma.
Clin Chem. 2006 Jun;52(6):1144-51
 
Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin.
Clin Chem. 2006 Jan;52(1):112-9
 
Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay.
Clin Chem. 2005 Oct;51(10):1823-9
 
Immunoluminometric assay for the midregion of pro-atrial natriuretic peptide in human plasma.
Clin Chem. 2004 Jan;50(1):234-6
 
Sensitive immunoluminometric assay for the detection of procalcitonin.
Clin Chem. 2002 May;48(5):788-90
 
 

 

Kardiologie
 
 
 
Schnabel RB, Wild PS, Schulz A, Zeller T, Sinning CR, Wilde S, Kunde J, Lubos E, Lackner KJ, Warnholtz A, Gori T, Blankenberg S, Munzel T; for the Gutenberg Health Study Investigators.
Multiple Endothelial Biomarkers and Noninvasive Vascular Function in the General Population: The Gutenberg Health Study.
Hypertension. 2012 Aug;60(2):288-295.




Gombos T, Makó V, Cervenak L, Papassotiriou J, Kunde J, Hársfalvi J, Förhécz Z, Pozsonyi Z, Borgulya G, Jánoskuti L, Prohászka Z.
Levels of von Willebrand factor antigen and von Willebrand factor cleaving protease (ADAMTS13) activity predict clinical events in chronic heart failure.
Thromb Haemost. 2009 Sep;102(3):573-80.


Caruhel P, Mazier C, Kunde J, Morgenthaler NG, Darbouret B.
Homogeneous time-resolved fluoroimmunoassay for the measurement of midregional proadrenomedullin in plasma on the fully automated system B.R.A.H.M.S KRYPTOR(®).
Clin Biochem. 2009 May;42(7-8):725-8




Immunoluminometric assay for measurement of the C-terminal endothelin-1 precursor
fragment in human plasma.
Clin Chem. 2006 Jun;52(6):1144-51
 
Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin.
Clin Chem. 2006 Jan;52(1):112-9
 
Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay.
Clin Chem. 2005 Oct;51(10):1823-9
 
Immunoluminometric assay for the midregion of pro-atrial natriuretic peptide in human plasma.
Clin Chem. 2004 Jan;50(1):234-6

 

Schilddrüse
 
TRAK-Bestimmung: Aktuelles für die klinische Praxis. Determination of TSH Receptor Autoantibodies: Current Recommendations for the Clinical Practice
Der Nuklearmediziner 2005;28:11-17
 
A coated tube assay for the detection of blocking thyrotropin receptor autoantibodies.
J Clin Endocrinol Metab. 2004 Jan;89(1):352-6
 
 
Affinity purification and diagnostic use of TSH receptor autoantibodies from human serum.
Mol Cell Endocrinol. 2003 Dec 30;212(1-2):73-9
 
Technical evaluation of a new immunoradiometric and a new immunoluminometric assay for thyroglobulin.
Clin Chem. 2002 Jul;48(7):1077-83
 
A luminescent bioassay for thyroid blocking antibodies.
Clin Endocrinol (Oxf). 2001 Mar;54(3):355-64
 
Development of serum-free bioreactor production of recombinant human thyroid stimulating hormone receptor.
Biotechnol Prog. 2000 Sep-Oct;16(5):703-9
 
[Clinical implications of a new TSH receptor antibody assay (DYNOtest TRAKhuman) in autoimmune thyroid diseases]
Nuklearmedizin. 2000;39(1):14-8
 
Development of a luminescent bioassay for thyroid stimulating antibodies.
J Clin Endocrinol Metab. 1999 Jan;84(1):374-7
 
Second generation assay for thyrotropin receptor antibodies has superior diagnostic sensitivity for Graves' disease.
J Clin Endocrinol Metab. 1999 Jan;84(1):90-7
 
Application of a bioassay with CHO cells for the routine detection of stimulating and blocking autoantibodies to the TSH-receptor.
Horm Metab Res. 1998 Mar;30(3):162-8 

 

Endokrinologie


Hollenbach B, Morgenthaler NG, Struck J, Alonso C, Bergmann A, Köhrle J, Schomburg L.
New assay for the measurement of selenoprotein P as a sepsis biomarker from serum.
J Trace Elem Med Biol. 2008;22(1):24-32
 
 

 

Neurodegeneration
 
Detection of stable N-terminal protachykinin A immunoreactivity in human plasma and cerebrospinal fluid.
Peptides. 2008 Jul;29(7):1201-6



 
Decreased serum amyloid beta(1-42) autoantibody levels in Alzheimer's disease, determined by a newly developed immuno-precipitation assay with radiolabeled amyloid beta(1-42) peptide.
Biol Psychiatry. 2005 Apr 1;57(7):813-6


Sonstige


 Schulte J, Struck J, Köhrle J, Müller B.
Circulating levels of Peroxiredoxin 4 as a Novel Biomarker of Oxidative Stress in Patients with Sepsis.
Shock. 2011 May;35(5):460-5


Schulte J, Struck J, Bergmann A, Köhrle J.
Immunoluminometric assay for quantification of peroxiredoxin 4 in human serum.
Clin Chim Acta. 2010 Sep 6;411(17-18):1258-63.


Bidlingmaier M, Suhr J, Ernst A, Wu Z, Keller A, Strasburger CJ, Bergmann A.
High-Sensitivity Chemiluminescence Immunoassays for Detection of Growth Hormone Doping in Sports.
Clin Chem. 2009 Mar;55(3):445-53